CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 8 enrolled
Drug / intervention
LDL Apheresisprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01138371
NCT01138371N/ACompleted
CompareCT.gov

Inflammatory and Lipid Markers Pre- and Post-LDL Apheresis: A Multicenter Experience

Emory University·observational·Posted Jun 7, 2010·Updated Dec 17, 2013

In Brief

An observational study evaluating LDL Apheresis for Familial Hypercholesterolemia. Completed, enrolled 8 participants across 1 site.

Detailed Summary

The primary objective of this study is to measure how LDL apheresis affects levels of inflammatory and cholesterol markers in human beings. The investigators will address this question by drawing pre- and post-LDL apheresis blood from patients who are undergoing this procedure. A secondary objective of this study is to learn how specific inflammatory markers behave in our blood in terms of time to rebound back to normal levels. The investigators will address this question by drawing post-LDL apheresis blood at predetermined time intervals.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsFamilial Hypercholesterolemia
CountriesUnited States
CollaboratorsKaneka Medical America LLC

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 7, 2010
Enrollment StartMar 1, 2011
Primary CompletionFeb 1, 2012
Study CompletionMar 1, 2012
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 16.1 years ago

Interventions

LDL Apheresisprocedure

LDL Apheresis